ScholarIQanswers from OpenAlex & ORCID
William C. Chapman
ResearcherPublications, citations & collaboration network
William C. Chapman is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does William C. Chapman have?
ScholarIQindexed works
William C. Chapman has 247 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does William C. Chapman have?
ScholarIQcitation count
William C. Chapman has 7,202 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of William C. Chapman?
ScholarIQh-index
William C. Chapman has an h-index of 47 in OpenAlex.
What is the i10-index of William C. Chapman?
ScholarIQi10-index
William C. Chapman has an i10-index of 118 in OpenAlex.
What is the ORCID of William C. Chapman?
ScholarIQorcid
The ORCID for William C. Chapman is on the source record.
What is the OpenAlex record for William C. Chapman?
ScholarIQopenalex
The OpenAlex for William C. Chapman is on the source record.
What are the most-cited papers on William C. Chapman?
ScholarIQmost cited works
Comparison of the transcriptional landscapes between human and mouse tissues
Shin Lin, Yiing Lin, Joseph R. Nery, Mark A. Urich, Alessandra Breschi, Carrie Davis, Alexander Dobin, Christopher Zaleski, M Beer, William C. Chapman, T Gingeras, Joseph R. Ecker, M Snyder
Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial
Paolo De Simone, Frank Nevens, Luciano De Carlis, Herold J. Metselaar, Susanne Beckebaum, Faouzi Saliba, Sven Jonas, Debra L. Sudan, John J. Fung, Lutz Fischer, Christophe Duvoux, Kenneth D. Chavin, Baburao Koneru, Mengyang Huang, William C. Chapman, Daniel Foltys, S. Witte, Hong Jiang, J. Mark Hexham, G. Junge
Outcomes of Neoadjuvant Transarterial Chemoembolization to Downstage Hepatocellular Carcinoma Before Liver Transplantation
William C. Chapman, Maria B. Majella Doyle, Jourdan E. Stuart, Neeta Vachharajani, Jeffrey S. Crippin, Christopher D. Anderson, Jeffrey A. Lowell, Surendra Shenoy, Michael Darcy, Daniel B. Brown
Renal Function at Two Years in Liver Transplant Patients Receiving Everolimus: Results of a Randomized, Multicenter Study
Faouzi Saliba, Paolo De Simone, Frank Nevens, Luciano De Carlis, Herold J. Metselaar, Susanne Beckebaum, Sven Jonas, Debra L. Sudan, Lutz Fischer, Christophe Duvoux, Kenneth D. Chavin, Baburao Koneru, Mengyang Huang, William C. Chapman, Daniel Foltys, Gaohong Dong, Patricia López, John J. Fung, G. Junge
Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation
Vatche G. Agopian, Michael P. Harlander‐Locke, Richard Ruiz, Göran B. Klintmalm, Srinath Senguttuvan, Sander Florman, Brandy Haydel, Maarouf Hoteit, Matthew H. Levine, David D. Lee, C. Burcin Taner, Elizabeth C. Verna, Karim J. Halazun, Rita M. Abdelmessih, Amit D. Tevar, Abhinav Humar, Federico Aucejo, William C. Chapman, Neeta Vachharajani, Mindie H. Nguyen, Marc L. Melcher, Trevor L. Nydam, Constance M. Mobley, R. Mark Ghobrial, Beth Amundsen, James F. Markmann, Alan N. Langnas, Carol A. Carney, Jennifer Berumen, Alan W. Hemming, Debra L. Sudan, Johnny C. Hong, Joohyun Kim, Michael A. Zimmerman, Abbas Rana, Michael Kueht, Christopher M. Jones, Thomas Fishbein, Ronald W. Busuttil